PABLO
ROJO CONEJO

2024

1. Afrontando la muerte: reuniones de duelo para profesionales en el cuidado pediátrico

   Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 101, Núm. 5, pp. 351-352

2. Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium

   The Lancet HIV, Vol. 11, Núm. 10, pp. e700-e710

3. Early inflammation as a footprint of increased mortality risk in infants living with HIV from three African countries

   Scientific Reports, Vol. 14, Núm. 1

4. Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe

   Pediatric Infectious Disease Journal, Vol. 43, Núm. 5, pp. E155-E159

5. High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries

   eClinicalMedicine, Vol. 73

6. Host gene expression signatures to identify infection type and organ dysfunction in children evaluated for sepsis: a multicentre cohort study

   The Lancet Child and Adolescent Health, Vol. 8, Núm. 5, pp. 325-338

7. Infective endocarditis in pediatric patients: a decade of insights from a leading Spanish heart surgery reference center

   European Journal of Pediatrics, Vol. 183, Núm. 9, pp. 3905-3913

8. Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART

   Frontiers in Immunology, Vol. 15

9. Penta Network: State-of-the-Art Research in Pediatric Human Immunodeficiency Virus

   Clinics in Perinatology, Vol. 51, Núm. 4, pp. 925-933

10. Planetary Health: What You Need to Know as a Pediatric Infectious Diseases Doctor

    Pediatric Infectious Disease Journal

11. Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory Diseases

    The Pediatric infectious disease journal, Vol. 43, Núm. 5, pp. 444-453

12. Randomised multicentre effectiveness trial of rapid syndromic testing by panel assay in children presenting to European emergency departments with acute respiratory infections-trial protocol for the ADEQUATE Paediatric trial

    BMJ Open, Vol. 14, Núm. 4

13. Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study

    Pediatrics, Vol. 153, Núm. 3

14. Renal Function Impairment in Children With Congenital Cytomegalovirus Infection: A Cross-sectional Study

    The Pediatric infectious disease journal, Vol. 43, Núm. 3, pp. 257-262

15. Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission

    Nature Medicine, Vol. 30, Núm. 10, pp. 2796-2804

16. Swissped-RECOVERY: masked independent adjudication for the interpretation of non-randomised treatment in a two-arm open-label randomised controlled trial (methylprednisolone vs immunoglobulins) in Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARSCoV-2 (PIMS-TS) involving 10 secondary and tertiary paediatric hospitals in Switzerland

    BMJ Open, Vol. 14, Núm. 4

17. T-Cell Immune Responses in Newborns and Long-Term Sequelae in Congenital Cytomegalovirus Infection (CYTRIC Study)

    Journal of Pediatrics, Vol. 272

18. The Need for RSV Prophylaxis in LMICs

    Pediatrics, Vol. 154, Núm. 4

19. The long wait for long-acting HIV prevention and treatment formulations

    The Lancet HIV, Vol. 11, Núm. 10, pp. e711-e716

20. Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain

    Pediatric Infectious Disease Journal, Vol. 43, Núm. 1, pp. 40-48